Pune-based Serum Institute of India (SII), the manufacturer of the Covishield vaccine, has been granted permission by the Drug Controller General of India (DCGI) to manufacture the Sputnik COVID-19 vaccine in India for examination, test, and analysis with certain conditions, official sources said on Friday. For the unversed, SII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V at its licensed Hadapsar facility. Also read COVID-19: Serum Institute applies to DCGI to manufacture Sputnik V vaccine in IndiaZee News quoted an official source as saying, "The DCGI has granted permission to the Serum Institute to manufacture the Sputnik COVID-19 vaccine in India for examination, test, and analysis at its licensed Hadapsar facility with certain conditions." Russia's Sputnik V vaccine is currently being manufactured by Dr Reddy's Laboratories in India. With the Drug Controller General of India granting permission, the Serum Institute of India (SII) has become the seventh company to manufacture Russia's Sputnik V vaccine.

Source: dna June 04, 2021 17:37 UTC